Pomerantz Law Firm Investigates Claims on Behalf of Investors of Gen-Probe Incorporated

Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of Gen-Probe Incorporated (“Gen-Probe” or the “Company”) (NASDAQ: GPRO) (ISIN: US36866T1034) concerning the proposed acquisition of Gen-Probe by Hologic, Inc. in a cash transaction valued at approximately $3.7 billion.

The investigation concerns whether the Gen-Probe directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the agreement, Gen-Probe shareholders would receive $82.75 in cash per share of Gen-Probe common stock. However, Gen-Probe Stock has traded as high as $86.66 in the last year. Additionally, there are $75 million in cost synergies that may not be reflected in the price to current Gen-Probe shareholders.

Gen-Probe shareholders seeking more information about this acquisition are advised to contact Rebecca Jarmon at rjarmon@pomlaw.com or 212-661-1100 or 888-476-6529, ext. 314.

The Pomerantz Firm, with offices in New York and Chicago, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.

GoPro (NASDAQ:GPRO)
Historical Stock Chart
From Jun 2024 to Jul 2024